Ö. Ataman

Randomized Phase II Study of Gefitinib Compared With Placebo in Chemotherapy-Naive Patients With Advanced Non–Small-Cell Lung Cancer and Poor Performance Status

Glenwood Goss, David Ferry, Rafal Wierzbicki et al. · Journal of Clinical Oncology · 2009 · 117 citations · Full text

Medicine, Oncology, Pharmacology +10

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors

David S. Boss, Petronella O. Witteveen, J. van der Sar et al. · Annals of Oncology · 2010 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase I study of barasertib (AZD1152), a selective inhibitor of Aurora B kinase, in patients with advanced solid tumors

Gary K. Schwartz, Richard D. Carvajal, Rachel Midgley et al. · Investigational New Drugs · 2012 · 80 citations

Medicine, Oncology, Pharmacology +10

First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE₂-receptor E-type 4 (EP4), in patients with advanced cancers

David S. Hong, Aparna R. Parikh, Geoffrey I. Shapiro et al. · Journal for ImmunoTherapy of Cancer · 2020 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

Improving the Capture of Adverse Event Data in Clinical Trials: The Role of the International Atomic Energy Agency

S.E. Davidson, Andy Trotti, Ö. Ataman et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 36 citations · Full text

Health Professions, Biomedical Informatics, Clinical Data Management +15